Market Overview:
The global beta-galactosidase assay kits market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for beta-galactosidase assay kits from academic and research institutes, pharmaceutical and biotechnology companies, hospitals and diagnostic laboratories, and others. Additionally, the growing awareness about enzyme assays is also contributing to the growth of this market.
Product Definition:
Beta-galactosidase assay kits are used to measure the amount of beta-galactosidase activity in a sample. The activity of beta-galactosidase is important for the breakdown of lactose into glucose and galactose.
Reagents:
Reagents are chemicals or substances that help in the detection of a specific substance or an activity. Reagents can be categorized as consumables and non-consumables. The major function of a reagent is to bring about an interaction between the substrate and the enzyme, which enables measurement of enzyme activity easily.
Assay Kits:
An assay kit is a collection of reagents and chemicals that are used for the detection of a particular disease or condition. The different types of assay kits available in the market include kits for diagnosis, monitoring, prevention, and treatment of various diseases. These products are gaining popularity owing to their ease-of-use and cost effectiveness.
Application Insights:
The academic and research institutes segment held the largest share of over 60.0% in 2017. The growth can be attributed to factors such as increasing R&D activities pertaining to biologics & drugs, along with an increase in government funding for medical research. Furthermore, growing number of clinical trials is also expected to contribute towards revenue generation during the forecast period.
Pharmaceutical and biotechnology companies are also anticipated to witness lucrative growth owing to factors such as an increase in product launches coupled with M&A activities undertaken by these companies for the purpose of enhancing their presence within specific therapeutic areas or gaining a competitive edge over their rivals.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to factors such as local presence of major players, higher disposable income, and increasing healthcare expenditure. Moreover, growing focus on drug discovery activities is expected to drive the demand for beta-galactosidase assays in this region. The U.S.
Asia Pacific is expected to witness lucrative growth during the forecast period owing to rising investments by governments & private entities coupled with favorable government policies regarding biotechnology industry development along with a high GDP per capita ratio which enables people from lower socio-economic backgrounds access advanced medical treatments at affordable costs thereby boosting adoption rates of these products across countries such as China Japan India Singapore Malaysia Indonesia Thailand Vietnam Australia New Zealand.
Growth Factors:
- Increasing demand for quality food products: The global population is growing at a rapid pace and the demand for quality food products is increasing correspondingly. This is driving the market for beta-galactosidase assay kits as they are essential for detecting lactose in food products.
- Growing awareness about lactose intolerance: There is a growing awareness about lactose intolerance among people across the globe. This is fueling the demand for beta-galactosidase assay kits as they help in detecting lactose in foods and beverages.
- Technological advancements: The market for beta-galactosidase assay kits is witnessing significant advancements with respect to technology, which is helping to boost its growth prospects globally. These technological advancements are making these assays more efficient and user-friendly, thereby widening their adoption rate among consumers worldwide.
Scope Of The Report
Report Attributes
Report Details
Report Title
Beta-Galactosidase Assay Kits Market Research Report
By Type
Reagents, Assay Kits
By Application
Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Hospitals and Diagnostic Laboratories, Others
By Companies
Merck, Thermo Fisher Scientific, Promega, Novus Biologicals (Bio-Techne), Abcam, Bio-Rad Laboratories, PromoCell, Geno Technology, Takara Bio, Agilent
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
214
Number of Tables & Figures
150
Customization Available
Yes, the report can be customized as per your need.
Global Beta-Galactosidase Assay Kits Market Report Segments:
The global Beta-Galactosidase Assay Kits market is segmented on the basis of:
Types
Reagents, Assay Kits
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Hospitals and Diagnostic Laboratories, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Merck
- Thermo Fisher Scientific
- Promega
- Novus Biologicals (Bio-Techne)
- Abcam
- Bio-Rad Laboratories
- PromoCell
- Geno Technology
- Takara Bio
- Agilent
Highlights of The Beta-Galactosidase Assay Kits Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Reagents
- Assay Kits
- By Application:
- Academic and Research Institutes
- Pharmaceutical and Biotechnology Companies
- Hospitals and Diagnostic Laboratories
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Beta-Galactosidase Assay Kits Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Beta-galactosidase assay kits are used to measure the level of beta-galactosidase in a sample. This enzyme is responsible for breaking down lactose into glucose and galactose. The level of beta-galactosidase in a sample can be used to determine whether or not the sample contains lactose.
Some of the major companies in the beta-galactosidase assay kits market are Merck, Thermo Fisher Scientific, Promega, Novus Biologicals (Bio-Techne), Abcam, Bio-Rad Laboratories, PromoCell, Geno Technology, Takara Bio, Agilent.
The beta-galactosidase assay kits market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Beta-Galactosidase Assay Kits Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Beta-Galactosidase Assay Kits Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Beta-Galactosidase Assay Kits Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Beta-Galactosidase Assay Kits Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Beta-Galactosidase Assay Kits Market Size & Forecast, 2020-2028 4.5.1 Beta-Galactosidase Assay Kits Market Size and Y-o-Y Growth 4.5.2 Beta-Galactosidase Assay Kits Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Reagents
5.2.2 Assay Kits
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Academic and Research Institutes
6.2.2 Pharmaceutical and Biotechnology Companies
6.2.3 Hospitals and Diagnostic Laboratories
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Beta-Galactosidase Assay Kits Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Beta-Galactosidase Assay Kits Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Reagents
9.6.2 Assay Kits
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Academic and Research Institutes
9.10.2 Pharmaceutical and Biotechnology Companies
9.10.3 Hospitals and Diagnostic Laboratories
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Reagents
10.6.2 Assay Kits
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Academic and Research Institutes
10.10.2 Pharmaceutical and Biotechnology Companies
10.10.3 Hospitals and Diagnostic Laboratories
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Reagents
11.6.2 Assay Kits
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Academic and Research Institutes
11.10.2 Pharmaceutical and Biotechnology Companies
11.10.3 Hospitals and Diagnostic Laboratories
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Reagents
12.6.2 Assay Kits
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Academic and Research Institutes
12.10.2 Pharmaceutical and Biotechnology Companies
12.10.3 Hospitals and Diagnostic Laboratories
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Reagents
13.6.2 Assay Kits
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Academic and Research Institutes
13.10.2 Pharmaceutical and Biotechnology Companies
13.10.3 Hospitals and Diagnostic Laboratories
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Beta-Galactosidase Assay Kits Market: Competitive Dashboard
14.2 Global Beta-Galactosidase Assay Kits Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Merck
14.3.2 Thermo Fisher Scientific
14.3.3 Promega
14.3.4 Novus Biologicals (Bio-Techne)
14.3.5 Abcam
14.3.6 Bio-Rad Laboratories
14.3.7 PromoCell
14.3.8 Geno Technology
14.3.9 Takara Bio
14.3.10 Agilent